GO
Loading...

Eli Lilly and Co

More

  • Early Glance: Pharmaceuticals companies Tuesday, 31 Mar 2015 | 10:29 AM ET

    Baxter International Inc. fell$. 17 or. 2 percent, to $68.59. Bristol-Myers Squibb Co. fell$. 59 or. 9 percent, to $65.17. Eli Lilly& Co. fell$. 04 or. 1 percent, to $73.83.

  • Final Glance: Pharmaceuticals companies Monday, 30 Mar 2015 | 5:56 PM ET

    Baxter International Inc. rose$. 21 or. 3 percent, to $68.76. Bristol-Myers Squibb Co. rose$. 50 or. 8 percent, to $65.76. Eli Lilly& Co. rose$. 29 or. 4 percent, to $73.87.

  • Midday Glance: Pharmaceuticals companies Monday, 30 Mar 2015 | 1:16 PM ET

    Baxter International Inc. fell$. 07 or. 1 percent, to $68.48. Bristol-Myers Squibb Co. rose$. 57 or. 9 percent, to $65.83. Eli Lilly& Co. rose$. 43 or. 6 percent, to $74.01.

  • Early Glance: Pharmaceuticals companies Monday, 30 Mar 2015 | 10:56 AM ET

    Baxter International Inc. fell$. 05 or. 1 percent, to $68.50. Bristol-Myers Squibb Co. rose$. 59 or. 9 percent, to $65.85. Eli Lilly& Co. rose$. 52 or. 7 percent, to $74.10.

  • Final Glance: Pharmaceuticals companies Friday, 27 Mar 2015 | 6:10 PM ET

    Baxter International Inc. rose$. 53 or. 8 percent, to $68.55. Bristol-Myers Squibb Co. rose$. 26 or. 4 percent, to $65.26. Eli Lilly& Co. rose$. 14 or. 2 percent, to $73.58.

  • Midday Glance: Pharmaceuticals companies Friday, 27 Mar 2015 | 1:16 PM ET

    Baxter International Inc. rose$. 42 or. 6 percent, to $68.44. Bristol-Myers Squibb Co. rose$. 48 or. 7 percent, to $65.48. Eli Lilly& Co. rose$. 45 or. 6 percent, to $73.89.

  • *Novo to submit interim trial data for Tresiba with FDA. The drug was rebuffed by the FDA two years ago. Citigroup's Peter Verdult said he believed the odds of U.S. approval were greater than 90 percent, given a small group of Novo staff sitting behind a communications "firewall" had already discussed the data with FDA.

  • Final Glance: Pharmaceuticals companies Thursday, 26 Mar 2015 | 6:07 PM ET

    Baxter International Inc. fell$. 12 or. 2 percent, to $68.02. Bristol-Myers Squibb Co. rose$. 30 or. 5 percent, to $65.00. Eli Lilly& Co. fell$. 92 or 1.2 percent, to $73.44.

  • Midday Glance: Pharmaceuticals companies Thursday, 26 Mar 2015 | 2:20 PM ET

    Baxter International Inc. rose$. 11 or. 2 percent, to $68.25. Bristol-Myers Squibb Co. rose$. 48 or. 7 percent, to $65.18. Eli Lilly& Co. fell$. 47 or. 6 percent, to $73.89.

  • Early Glance: Pharmaceuticals companies Thursday, 26 Mar 2015 | 10:34 AM ET

    Baxter International Inc. rose$. 04 or. 1 percent, to $68.18. Bristol-Myers Squibb Co. fell$. 08 or. 1 percent, to $64.62. Eli Lilly& Co. fell$. 61 or. 8 percent, to $73.75.

  • Final Glance: Pharmaceuticals companies Wednesday, 25 Mar 2015 | 6:03 PM ET

    Baxter International Inc. fell$. 36 or. 5 percent, to $68.14. Bristol-Myers Squibb Co. fell$. 99 or 1.5 percent, to $64.70. Eli Lilly& Co. fell $1.20 or 1.6 percent, to $74.36.

  • Midday Glance: Pharmaceuticals companies Wednesday, 25 Mar 2015 | 1:43 PM ET

    Baxter International Inc. fell$. 15 or. 2 percent, to $68.35. Bristol-Myers Squibb Co. fell$. 47 or. 7 percent, to $65.22. Eli Lilly& Co. fell$. 87 or 1.2 percent, to $74.69.

  • Early Glance: Pharmaceuticals companies Wednesday, 25 Mar 2015 | 11:55 AM ET

    Baxter International Inc. rose$. 03 or percent, to $68.53. Bristol-Myers Squibb Co. fell$. 14 or. 2 percent, to $65.55. Eli Lilly& Co. fell$. 29 or. 4 percent, to $75.27.

  • Final Glance: Pharmaceuticals companies Tuesday, 24 Mar 2015 | 8:17 PM ET

    Baxter International Inc. fell$. 34 or. 5 percent, to $68.50. Bristol-Myers Squibb Co. fell $1.89 or 2.8 percent, to $65.69. Eli Lilly& Co. fell$. 80 or 1.0 percent, to $75.56.

  • Midday Glance: Pharmaceuticals companies Tuesday, 24 Mar 2015 | 1:19 PM ET

    Baxter International Inc. fell$. 33 or. 5 percent, to $68.51. Bristol-Myers Squibb Co. fell $1.45 or 2.1 percent, to $66.13. Hospira fell$. 03 or percent, to $87.85.

  • Early Glance: Pharmaceuticals companies Tuesday, 24 Mar 2015 | 10:22 AM ET

    Baxter International Inc. fell$. 14 or. 2 percent, to $68.70. Bristol-Myers Squibb Co. fell$. 90 or 1.3 percent, to $66.68. Eli Lilly& Co. rose$. 14 or. 2 percent, to $76.50.

  • Final Glance: Pharmaceuticals companies Monday, 23 Mar 2015 | 6:03 PM ET

    Baxter International Inc. rose$. 66 or 1.0 percent, to $68.84. Eli Lilly& Co. rose$. 24 or. 3 percent, to $76.36. Hospira rose$. 24 or. 3 percent, to $87.88.

  • Pfizer and ImmunoGen are big market movers Monday, 23 Mar 2015 | 4:45 PM ET

    NEW YORK— Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:. Pfizer Inc., up 80 cents to $35.05. Cliffs Natural Resources Inc., up 51 cents to $4.81.

  • March 23- The U.S. Food and Drug Administration said it would not recommend changes to the prescribing or use of Eli Lilly and Co's schizophrenia drug after a review of two deaths. The FDA said its investigation into the deaths was inconclusive. It carries a boxed warning, FDA's most serious type of warning, for post-injection delirium sedation or olanzapine...

  • March 23- The U.S. Food and Drug Administration said it would not recommend changes to the prescribing or use of Eli Lilly and Co's schizophrenia drug after a review of two deaths. Elevated levels of the drug, Zyprexa Relprevv, were found in the two patients who died three to four days after receiving the injection. The FDA said its investigation into the deaths was...